Funding
← Back to your selection

CE-Ventures

Activity from announced rounds

Activity in this selectionOct 16, 2026 · Sep 17, 2026

CE-Ventures is the venture investment brand named in Think Bioscience and Aptadir financing coverage.

Recorded funding activity

Think Bioscience develops small-molecule drugs for difficult targets. Aptadir develops RNA therapeutics intended to restore expression of silenced genes. Their retained announcements establish the two investment relationships without substituting a parent corporation or an unnamed individual fund.

Sources
Rounds participated in
1
Confirmed lead rounds
0
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$45.4M
1 disclosed · full round size, not this investor’s share

By stage

Seed1

By primary sector

Biotech1

By country

Italy1

Rounds

1 in this selection